NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
June 9, 2026 — BOXABL unveils UFO, a foldable lunar habitat concept, and makes its IP royalty-free to spur off-world innovation. Learn how this impacts space settlement and housing tech.
June 9, 2026 — Lexston Mining engages Dentons Delany for Guyana expansion, securing legal services for incorporation, tax registration, and mining law advice. CEO Jag Bal to visit Guyana June 15 to review projects. (OTCQB: LEXTF)
June 9, 2026 — Ostara announces a new higher-analysis CG P2X fertilizer with 9-42-0 analysis delivering 30% more nitrogen and phosphorus, helping growers reduce nutrient loss and improve efficiency.
June 9, 2026 — LataMed AI Corp. evaluates deploying AI health platforms in fitness and wellness markets. Learn about their strategic growth initiative and potential impact on digital health.
June 9, 2026 — PhillComm Global adds Bond and Klarify to its client roster, expanding into AI-driven personal security and healthcare admin automation. Learn how these innovations address societal shifts.
June 9, 2026 — Generation Uranium presents at Emerging Growth Conference on June 11, 2026, highlighting Yath Uranium Project with 17 targets. Investors can engage with CEO live.
June 8, 2026 — Rejuvenate Bio and Eisana Health win top honors at Superpowers for Good Live Pitch, showcasing gene therapy for longevity and a cooling system for chemotherapy side effects.
June 8, 2026 — Readcrest Capital AG publishes 2026 guidance: adjusted EBITDA €8-9M. Focus shifts to German residential projects after UK care home sale. Key milestones include Dresden and Halle developments.
June 8, 2026 — Regentis Biomaterials (NYSE American: RGNT) announces surgeon training for GelrinC, a CE Mark-approved knee cartilage treatment, starting Q3 2026 in Europe.
June 8, 2026 — Miami small businesses prepare for tourist surge from Formula 1 and FIFA World Cup. One Park Financial offers fast working capital to help them meet demand.
June 8, 2026 — Foresight (FRSX) invests up to $17.5M in VisionWave (VWAV) to merge sensing and AI for defense solutions like counter-drone systems. A strategic alliance for advanced perception.
June 8, 2026 — The Deady Group sharpens focus on technology procurement, utility procurement, and recurring spend management for regulated and innovation-driven organizations, offering vendor-neutral guidance to reduce costs by 15-30%.
June 8, 2026 — CNS Pharmaceuticals (CNSP) completes $22.5M oversubscribed financing, CFO discusses strategic reset and acquisition-focused transformation. InvestorWire covers the virtual segment highlighting institutional investor interest and growth strategy.
June 8, 2026 — Tonix Pharmaceuticals expands TONMYA access to 52 million U.S. commercial lives via new coverage agreement. Learn about the fibromyalgia treatment and its impact.
June 8, 2026 — Regentis Biomaterials announces European surgeon training for GelrinC, a CE Mark-approved cell-free knee cartilage implant, starting Q3 2026 at Humanitas Research Hospital in Milan.
June 8, 2026 — Xeriant's NexBoard achieves Class A fire rating in ASTM E84 testing, validating it as a fire-resistant alternative to drywall. The eco-friendly panel also resists water, mold, and insects, targeting sustainable construction.
June 8, 2026 — Core AI Holdings is transforming online gaming with AI, as highlighted by TechMediaWire. Discover how AI readiness is crucial for business success and why this matters for investors and tech enthusiasts.
June 8, 2026 — Redwood AI gains traction with AI platform for government, defense, and healthcare. Partnerships with Canadian agencies and proposed Quantum.IQ acquisition highlight growth.
June 8, 2026 — Quantum BioPharma advances LUCID-MS for multiple sclerosis, completing Phase 1 trials and submitting an IND to FDA. Learn about this novel therapy targeting myelin repair.
June 8, 2026 — TransCode Therapeutics announces first live R&D webcast on June 18, 2026, highlighting Phase 2a trial of TTX-MC138 in colorectal cancer. Learn about updates to its RNA therapy pipeline.